Download full-text PDF |
Source |
---|
Microb Drug Resist
January 2025
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Carbapenenemase producers, particularly the metallo-β-lactamase (MBL) types in , have emerged as an urgent threat in health care settings. MBLs require zinc at their catalytic site and can be inhibited by dimercaptosuccinic acid (DMSA), a metal chelator known for the treatment of lead and mercury intoxication. Isogenic strains of wild-type and OprD-deleted PA14, were constructed, producing the MBLs VIM-2, NDM-1, SPM-1, IMP-1, and AIM-1, or the non-MBL carbapenemases, GES-5 and KPC-2.
View Article and Find Full Text PDFClin Toxicol (Phila)
May 2023
Toxicology Unit, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Clin Toxicol (Phila)
March 2023
Public Health Institute, Ostrava, Czech Republic.
Toxicon
October 2022
Venom Evolution Lab, School of Biological Science, University of Queensland, St. Lucia, QLD, Australia. Electronic address:
Venoms are evolutionary novelties that have real-world implications due to their impact upon human health. However, relative to the abundant studies of elapid and viperid snake venoms, fewer investigations have been undertaken on those of rear-fanged snakes as they are more problematic for obtaining venom. While most rear-fanged venomous snakes are not considered to be of great medical importance, several species are capable of producing fatalities.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!